Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Actively gather additional information on the use of CorMatrix CanGaroo ECM Envelope in a post market observational study.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Implantable electronic device placement | CorMatrix CanGaroo ECM envelope for an implantable electronic device placement following a battery change out or upgrade. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| CorMatrix CanGaroo ECM Envelope | Device | Subjects who have received CorMatrix CanGaroo ECM Envelope for an implantable electronic device placement following a battery change or upgrade. |
| Measure | Description | Time Frame |
|---|---|---|
| Device Related Adverse Events | 1 day post-operative follow up visit |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
1. Known sensitivities to porcine material.
Not provided
Not provided
Not provided
Not provided
The study population will consist of any subject who has received the CorMatrix CanGaroo ECM Envelope for an implantable electronic device placement following a battery change out or upgrade.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Director, Clinical Development | Aziyo Biologics | Study Director |
Not provided
Not provided
| ID | Term |
|---|---|
| D003327 | Coronary Disease |
| ID | Term |
|---|---|
| D017202 | Myocardial Ischemia |
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
| D014652 | Vascular Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided